252 related articles for article (PubMed ID: 24173184)
1. Cutaneous field cancerization: clinical, histopathological and therapeutic aspects.
Torezan LA; Festa-Neto C
An Bras Dermatol; 2013; 88(5):775-86. PubMed ID: 24173184
[TBL] [Abstract][Full Text] [Related]
2. A genetic explanation of Slaughter's concept of field cancerization: evidence and clinical implications.
Braakhuis BJ; Tabor MP; Kummer JA; Leemans CR; Brakenhoff RH
Cancer Res; 2003 Apr; 63(8):1727-30. PubMed ID: 12702551
[TBL] [Abstract][Full Text] [Related]
3. Field cancerization: concept and clinical implications in head and neck squamous cell carcinoma.
Jaiswal G; Jaiswal S; Kumar R; Sharma A
J Exp Ther Oncol; 2013; 10(3):209-14. PubMed ID: 24416996
[TBL] [Abstract][Full Text] [Related]
4. Field cancerization: Treatment.
Cornejo CM; Jambusaria-Pahlajani A; Willenbrink TJ; Schmults CD; Arron ST; Ruiz ES
J Am Acad Dermatol; 2020 Sep; 83(3):719-730. PubMed ID: 32387663
[TBL] [Abstract][Full Text] [Related]
5. Cancer stem cells and field cancerization of oral squamous cell carcinoma.
Simple M; Suresh A; Das D; Kuriakose MA
Oral Oncol; 2015 Jul; 51(7):643-51. PubMed ID: 25920765
[TBL] [Abstract][Full Text] [Related]
6. Management of field change in actinic keratosis.
Vatve M; Ortonne JP; Birch-Machin MA; Gupta G
Br J Dermatol; 2007 Dec; 157 Suppl 2():21-4. PubMed ID: 18067627
[TBL] [Abstract][Full Text] [Related]
7. Field cancerization: Definition, epidemiology, risk factors, and outcomes.
Willenbrink TJ; Ruiz ES; Cornejo CM; Schmults CD; Arron ST; Jambusaria-Pahlajani A
J Am Acad Dermatol; 2020 Sep; 83(3):709-717. PubMed ID: 32387665
[TBL] [Abstract][Full Text] [Related]
8. Oral field cancerization: history and future perspectives.
Gabusi A; Morandi L; Asioli S; Foschini MP
Pathologica; 2017 Mar; 109(1):60-65. PubMed ID: 28635994
[TBL] [Abstract][Full Text] [Related]
9. Second field tumors: a new opportunity for cancer prevention?
Braakhuis BJ; Brakenhoff RH; Leemans CR
Oncologist; 2005 Aug; 10(7):493-500. PubMed ID: 16079316
[TBL] [Abstract][Full Text] [Related]
10. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck.
Hong WK; Lippman SM; Itri LM; Karp DD; Lee JS; Byers RM; Schantz SP; Kramer AM; Lotan R; Peters LJ
N Engl J Med; 1990 Sep; 323(12):795-801. PubMed ID: 2202902
[TBL] [Abstract][Full Text] [Related]
11. Investigating a case of possible field cancerization in oral squamous cell carcinoma by the use of next-generation sequencing.
Tabatabaeifar S; Larsen MJ; Larsen SR; Kruse TA; Thomassen M; Sørensen JA
Oral Oncol; 2017 May; 68():74-80. PubMed ID: 28438297
[TBL] [Abstract][Full Text] [Related]
12. Genetically altered fields in head and neck cancer and second field tumor.
Sabharwal R; Mahendra A; Moon NJ; Gupta P; Jain A; Gupta S
South Asian J Cancer; 2014 Jul; 3(3):151-3. PubMed ID: 25136520
[TBL] [Abstract][Full Text] [Related]
13. The molecular biology of mucosal field cancerization of the head and neck.
Ha PK; Califano JA
Crit Rev Oral Biol Med; 2003; 14(5):363-9. PubMed ID: 14530304
[TBL] [Abstract][Full Text] [Related]
14. An overview of the risk factors associated with multiple oral premalignant lesions with a case report of extensive field cancerization in a female patient.
Sreedhar G; Narayanappa Sumalatha M; Shukla D
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):178-83. PubMed ID: 24401899
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease in head and neck cancer.
Gath HJ; Brakenhoff RH
Cancer Metastasis Rev; 1999; 18(1):109-26. PubMed ID: 10505550
[TBL] [Abstract][Full Text] [Related]
16. Could field cancerization be interpreted as a biochemical anomaly amplification due to transformed cells?
Fernández P J; Méndez-Sánchez SC; Gonzalez-Correa CA; Miranda DA
Med Hypotheses; 2016 Dec; 97():107-111. PubMed ID: 27876116
[TBL] [Abstract][Full Text] [Related]
17. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
18. Perineural infiltration by cutaneous squamous cell carcinomas of the head and neck.
Di Gregorio C; Gebbia V; Florena AM; Franco V; Moschella F
Anticancer Res; 1995; 15(3):1107-15. PubMed ID: 7645933
[TBL] [Abstract][Full Text] [Related]
19. Surgical approach to the management of field cancerization: Own experience.
Wójcicka K; Szepietowski JC
Dermatol Ther; 2020 Jul; 33(4):e13621. PubMed ID: 32430938
[TBL] [Abstract][Full Text] [Related]
20. Association between aldehyde dehydrogenase gene polymorphisms and the phenomenon of field cancerization in patients with head and neck cancer.
Muto M; Nakane M; Hitomi Y; Yoshida S; Sasaki S; Ohtsu A; Yoshida S; Ebihara S; Esumi H
Carcinogenesis; 2002 Oct; 23(10):1759-65. PubMed ID: 12376487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
